MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    The use of a clinical “exercise -immobility test” in a patient with paroxysmal hypnogenic dyskinesia

    A. Shalash, A. Abushouk, H. Elrasas (Cairo, Egypt)

    Objective: We present a patient of PHD that occurred also after immobility without sleep and its severity increases in days of more exertion. Furthermore, we…
  • 2018 International Congress

    Atypical Dopamine Responsive Parkinsonism in HIV Seroconversion

    N. Siddi Ganie, I. Siddi Ganie, N. Soni (Durban, South Africa)

    Objective: To add to the current body of knowledge of the association of HIV infection and dopamine responsive parkinsonism. Background: South Africa has one of…
  • 2018 International Congress

    Revision of Diagnosis in Early Parkinsonism with Abnormal Dopamine Transporter Imaging: A Case Series from the PPMI Study

    J. Massa, L. Chahine (Pittsburgh, PA, USA)

    Objective: To describe the characteristics of patients initially diagnosed with idiopathic Parkinson’s Disease (PD) and with abnormal dopamine transporter (DAT) imaging who have a change…
  • 2018 International Congress

    Atypical Response to Apomorphine in a Patient with Multiple System Atrophy

    S. Ozben, F. Genc, F. Tuter Yilmaz, A. Erdal, N. Atis (Antalya, Turkey)

    Objective: Multiple system atrophy (MSA) is a sporadic neurodegenerative disease clinically characterized by cerebellar signs, parkinsonism and autonomic dysfunction. MSA is classified into two sub-types;…
  • 2018 International Congress

    Comparative study of the cognitive and behavioral disturbances between progressive supranuclear palsy phenotypes

    A. Horta-Barba, J. Pagonabarraga, S. Martinez-Horta, I. Illán, I. Aracil, J. Pérez-Pérez, B. Pascual, H. Bejr-Kasem, J. Marin, F. Sampedro, M. Botí, C. Izquierdo, A. Campolongo, J. Kulisevsky (Barcelona, Spain)

    Objective: Explore cognitive and behavioural disturbances between subtypes of progressive supranuclear palsy (PSP). Background: Although clinical diagnosis of PSP is based on specific motor symptoms,…
  • 2018 International Congress

    18F-FDG PET brain in Parkinsonism

    F. Amod (Durban, South Africa)

    Objective: To determine if 18F-FDG PET can differentiate Parkinson's Disease from Parkinson's-Plus syndromes Background: Parkinsonism is a clinical syndrome of tremor, rigidity, bradykinesia and postural…
  • 2018 International Congress

    Likelihood ratios of prodromal diagnostic markers for Chinese Parkinson’s disease: A systematic review and meta-analysis

    S.Y. Liu, Z. Zheng, Z.Q. Gu, C.D. Wang, P. Chan (Beijing, China)

    Objective: MDS has published the research criteria for prodromal Parkinson’s disease (PD). This study is to estimate the likelihood ratios (LR) of prodromal diagnostic markers…
  • 2018 International Congress

    Postural Sway Complexity as a Measure of Motor Functionality in Fragile X Premutation Carriers

    C. O'Keeffe, L. Taboada, N. Feerick, L. Gallagher, T. Lynch, R. Reilly (Dublin, Ireland)

    Objective: To assess changes in motor functionality of FMR1 premutation carriers at risk of developing Fragile X Associated Tremor/Ataxia Syndrome(FXTAS), through traditional and complexity-based measures…
  • 2018 International Congress

    Predictive factors of quality of life evolution in Parkinson’s disease patients participating in a therapeutic patient education program

    C. Derollez, N. Carriere, D. Haidon, M. Kyheng, S. Peres, L. Defebvre (Lille, France)

    Objective: Identify factors associated with an improvement in quality of life in Parkinson’s disease (PD) among patients participating to a therapeutic education program. Background: Therapeutic…
  • 2018 International Congress

    Frailty in Patients with Parkinson’s Disease: Associations with Disability and Timed Up and Go Test

    F. Fırat Ozer, S. Akın, M. Gultekin, G. Erturk, A. Ekinci (Kayseri, Turkey)

    Objective: To identify the prevelance of frailty in patients with Idiopathic Parkinson’s disease (PD), to describe the relationship between severity of the disease and frailty,…
  • « Previous Page
  • 1
  • …
  • 93
  • 94
  • 95
  • 96
  • 97
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley